LiveActive security incident?Get immediate response
CVE Record

CVE-2021-23195: Fresenius Kabi Agilia Connect Infusion System exposure of information through directory listing

Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard) version 2.0.1.3 has the option for automated indexing (directory listing) activated. When accessing a directory, a web server delivers its entire content in HTML form. If an index file does not exist and directory listing is enabled, all content of the directory will be displayed, allowing an attacker to identify and access files on the server.

MediumCVSS 5.3Not KEV-listedUpdated
Glexia's TakeAutomated analysismoderate

Security readout for executives and security teams

Plain-English summary

This CVE concerns a medical infusion-system management dashboard that may show server directory contents to anyone who can reach it. The business risk is unintended disclosure of files, paths, or configuration clues, not direct device takeover based on the provided evidence.

Executive priority

Treat as a moderate confidentiality issue for healthcare environments. Prioritize confirming exposure and applying vendor-approved remediation, especially if the dashboard is reachable beyond tightly controlled internal networks.

Technical view

Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard) 2.0.1.3 has automated indexing enabled. If a directory lacks an index file, the web server may return a listing of available files. CVSS 3.1 is 5.3, with network access, low complexity, no privileges, and low confidentiality impact.

Likely exposure

Exposure is most relevant where Mastermed Dashboard is reachable over hospital, vendor, or remote-access networks. Internet exposure would raise urgency, but the bundle does not state that systems are commonly internet-facing.

Exploitation context

The source bundle does not identify active exploitation, and the CVE is not marked as CISA KEV. The issue is easy to trigger for reachable systems, but documented impact is limited to information disclosure.

Researcher notes

The vulnerability maps to CWE-548. Evidence supports directory listing information disclosure only. The bundle does not provide exploit-in-the-wild evidence, affected CPEs, or a named fixed version, so avoid broader product claims.

Mitigation direction

  • Review Fresenius Kabi and CISA advisory guidance for supported remediation.
  • Disable directory listing where vendor-supported and change-controlled.
  • Restrict dashboard access to trusted clinical engineering or management networks.
  • Require authenticated VPN or equivalent access for remote administration.
  • Monitor web logs for unusual directory browsing patterns.

Validation and detection

  • Inventory deployments of Vigilant Software Suite or Mastermed Dashboard.
  • Confirm whether version 2.0.1.3 is present.
  • Check whether dashboard directories expose file listings without intended index pages.
  • Verify the dashboard is not reachable from untrusted networks.
  • Document compensating controls and vendor remediation status.
Prepared
Confidence
high
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-548: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2021-23195 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Medium
CVSS
5.3 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
5.3CVSS 3.1MediumCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N3.91.4Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

5.3Medium
CVSS 3.1 vector shape for CVE-2021-23195Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Fresenius KabiVigilant Software Suite (Mastermed Dashboard)unspecifiedListed
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-548 · source CWE mapping

Exposure of Information Through Directory Listing

Exposure of Information Through Directory Listing represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.